# Guangzhou Ruitai Biotechnology Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/guangzhou-ruitai-biotechnology-co

- Industry: Medical Devices & Equipment
- Headquarters: Guangzhou, China
- Website: www.amvisionbio.com
- Total disclosed funding: $14M
- Latest round: Series A (Mar 9, 2023)
- Investors on record: 4

## About

Based in Guangzhou China and founded in 2014, Guangzhou Ruitai Biotechnology Co., Ltd. operates as a high-tech enterprise specializing in the research and development, production and sales of regenerative repair materials and its related medical device products. The company completed the development and clinical work of biological amniotic membrane products for ophthalmology in 2018, obtained the Registration Certificate of Medical Devices of the People's Republic of China issued by the State Drug Administration in 2019, and obtained the Medical Device Manufacturing License in 2020. Hao Xu, the founder of the company, has served as the head of ophthalmology sales for companies such as Merck, Pfizer, and Shenzhen Ruilin Medicine.

The company independently developed the wet biological amniotic membrane (Rixiufu®), which is an active biological material that can solve various ophthalmic diseases from the ocular surface to the fundus. It is mainly used in ocular surface reconstruction and more than 200 hosipitals. The company has a rich pipeline of research and development, and the products are covering ocular surface damage, dry eye, glaucoma, fundus macular hole, optometry and other fields.

## Funding rounds

- Series A, Mar 9, 2023, $14M — Green Pine Capital Partners, Zhongda Venture Capital, HM Capital
- Series A, Apr 26, 2022 — Guangzhou Industry Investment Holding Group, HM Capital

## Investors

- Guangzhou Industry Investment Holding Group (https://capitalatlas.ai/funds/guangzhou-industry-investment-holding-group) — Series A
- HM Capital (https://capitalatlas.ai/funds/hm-capital) — Series A
- Green Pine Capital Partners (https://capitalatlas.ai/funds/green-pine-capital-partners) — Series A
- Zhongda Venture Capital (https://capitalatlas.ai/funds/zhongda-venture-capital) — Series A